Furthermore, P53 protein expression was monitored under the tested treatment conditions, and as shown in Figure 4b,c, P53 levels did not change in either NB cell populations as well as the expression levels of p21, a P53-downstream protein, and MDM2, a negative modulator of P53 [59]. The gene discussed is TP53; the disease is neuroblastoma.